BMS sues Teva over Reyataz ANDA
07 December 2009
Nancy Faigen
Bristol-Myers Squibb has filed a patent infringement suit in the US District Court for the District of Delaware against
Teva Pharmaceutical Industries alleging patent infringement related to its proposed generic version of the HIV protease inhibitor, Reyataz (atazanavir sulfate), thus triggering a...
Please Login to read the full article.
07 December 2009
Nancy Faigen
Please Login to read the full article.
RELATED CONTENT
NEWS
- Watson beatsTeva on appeals overgeneric Seasonique: sued by Novartis over Exelon
- Sandoz wants Novo's sole US Prandin patent ruled invalid in a long running case
- Watson beats Cephalon's cheeky, fizzy fentanyl patents
- Cubist value jumps $250 million on Cubicin patent settlement with Teva
COMMENT
Other Informa Comment
EVENTS
09 February 2012
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
